Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2026-01-09 @ 6:15 PM
Study NCT ID:
NCT02596035
Status:
COMPLETED
Last Update Posted:
2022-10-27
First Post:
2015-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-08
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-02
First Submit QC Date:
None
Study First Post Date:
2015-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-04-29
Results First Submit QC Date:
None
Results First Post Date:
2019-08-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-25
Last Update Post Date:
2022-10-27
Last Update Post Date Type:
ACTUAL